Lower-Dose Regeneron Antibody Cocktail Is 'Game-Changing': CSO

The video discusses an antibody cocktail that reduces COVID-19 hospitalization and death by 70%. It highlights the treatment's effectiveness against emerging variants and emphasizes the importance of distribution and access. The supply has increased to meet high-risk patient needs, and the treatment is free for patients. The video calls for action from healthcare providers to ensure widespread use, potentially reducing variant spread and supporting vaccine efforts.

What is the current supply outlook for the antibody treatments?

What moral imperative is highlighted regarding the treatment of high-risk patients?

What role do physicians and hospitals play in the distribution of the antibody treatment?